Thopaz+ allows healthcare professionals to make informed decisions based on precise drainage data.
Find out how to shorten hospital stay and save costs using Thopaz+.
Compact, lightweight, portable unit with convenient carrying handle
Provides uninterrupted drainage in care settings, including those without access to central vacuum, enabling use in temporary COVID-19 patient care centers or for non-COVID-19 patients who are being moved away from dedicated COVID-19 wards.
At a national level, adopting Thopaz+ is expected to save around £8.5 million per year in England.” Thopaz+ reduces chest tube duration and length of stay (in hospital).
Thopaz+ Improves safety for people with chest drains.
Thopaz+ Improves clinical decision-making through continuous objective monitoring of air leaks and fluid loss.
Thopaz+ Increases patient mobility.
Healthcare providing staff finds Thopaz+ more convenient and easier to use than conventional chest drains.
Improving outcomes and streamlining care – clinically proven
Thopaz+ allows the optimal pressure to be applied for post-operative chest drainage management, and permits objective and reliable monitoring of patient status. As a result, the length of hospital stay can be shortened by at least 1 day 1, 2, 6, 7 with the corresponding reduction in hospital costs 1–5.
Company Name: Medela Ag